Company Profile

Cellerant Therapeutics Inc (AKA: Celtrans LLC)
Profile last edited on: 1/14/19      CAGE: 47BJ6      UEI: LML1YE6L8KU3

Business Identifier: Oroducts for regulation of hematopoietic system (blood-forming)
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1561 Industrial Road
San Carlos, CA 94070
   (650) 232-2122
Location: Single
Congr. District: 14
County: San Mateo

Public Profile

Cellerant Therapeutics, formerly doing business as Celtrans LLC, is a clinical stage biotechnology company developeing a portfolio of products based on the regulation of hematopoietic (blood-forming) systems. The company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008), as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company also has a Cancer Stem Cell (CSC) antibody discovery program focused on therapies for acute myeloid leukemia, multiple myeloma and myelodysplastic syndrome.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Ram Mandalam -- President; Chief Executive Officer

  Elisa Brunette -- Director of Technology Transfer

  Julie L Christensen

  Bruce Cohen

  Margaret Dillon -- Senior Vice President, Regulatory Affairs, Quality Assurance & Project Managemen

  Jos Domen

  Timothy C Fong

  Jagath Juntula

  Holger Karsunky

  Swapna Panuganti

  William Reed -- Vice President, Clinical Development

  David C Scherer

  Robert Tressler -- Vice President of Research & Development

  Jun S Yoon -- Director of Corporate Development

  Jun S Yoon -- Vice President, Corporate Development

  Rodney Young -- Chief Financial Officer

  Deborah Zimmerman